Cell Signaling Technology

PIP5K1A Antibody

#9693 · $317

100
Citing papers
3.7k
Combined citations
Supplier page Find this product

Research areas

DNA Repair Mechanisms17Cancer-related Molecular Pathways10Neuroscience and Neuropharmacology Research7interferon and immune responses7Microtubule and mitosis dynamics7Cancer, Hypoxia, and Metabolism6CRISPR and Genetic Engineering6Respiratory viral infections research6

Papers citing this product

1
Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in <i>BRCA</i> -Mutant Ovarian Cancer Models
Clinical Cancer Research·2016·292 cit.·DOI
2
VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2
Cell Death and Differentiation·2009·192 cit.·DOI
3
Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
British Journal of Cancer·2012·165 cit.·DOI
4
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner
Nature Communications·2019·161 cit.·DOI
5
Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways
Laboratory Investigation·2013·146 cit.·DOI
6
Compound developmental eye disorders following inactivation of TGFβ signaling in neural-crest stem cells
Journal of Biology·2005·127 cit.·DOI
7
RET rearrangements are actionable alterations in breast cancer
Nature Communications·2018·126 cit.·DOI
8
An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation
The Journal of Experimental Medicine·2012·114 cit.·DOI
9
Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
BMC Cancer·2014·110 cit.·DOI
10
RNF4 and PLK1 are required for replication fork collapse in ATR-deficient cells
Genes & Development·2013·108 cit.·DOI